Identification of budesonide and prednisone as substrates of the intestinal drug efflux pump P-glycoprotein.
about
Oral budesonide for induction of remission in ulcerative colitisA Study of Human Killer Cell Immunoglobulin-Like Receptor and Multidrug Resistance Gene Polymorphisms in Children With Immune Thrombocytopenia.MDR1 polymorphisms and idiopathic nephrotic syndrome in Slovak children: preliminary results.Genetic variants and the risk of Crohn's disease: what does it mean for future disease management?Review article: interactions between genotype and response to therapy in inflammatory bowel diseases.Drug metabolism and pharmacokinetics.Budesonide for Crohn's disease.Prodrug strategies in ocular drug delivery.Oral locally active steroids in inflammatory bowel disease.Drug choices in autoimmune hepatitis: part A--Steroids.Drug Management in the Elderly IBD Patient.Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment.In vitro drug-drug interactions of budesonide: inhibition and induction of transporters and cytochrome P450 enzymes.Continuous Intestinal Absorption Model Based on the Convection-Diffusion Equation.Budesonide for the treatment of ulcerative colitis.CYP3A4 Activity is Markedly Lower in Patients with Crohn's Disease.Triblock polymeric micelles as carriers for anti-inflammatory drug delivery.Renal Drug Transporters and Drug Interactions.Effect of Eclipta prostrata on 11Beta-Hydroxysteroid Dehydrogenase in Rat Liver and Kidney.Effects of budesonide on P-glycoprotein expression in intestinal cell lines.Gastrointestinal transit, release and plasma pharmacokinetics of a new oral budesonide formulationMDR1 gene: susceptibility in Spanish Crohn's disease and ulcerative colitis patients.Polymorphisms of the MDR1 and MIF genes in children with nephrotic syndrome.ABCB1 polymorphisms and steroid treatment in children with idiopathic nephrotic syndrome.Brain permeability of inhaled corticosteroids.Pharmacokinetics and pharmacodynamic action of budesonide in children with Crohn's disease.NR3C1 gene polymorphisms are associated with steroid resistance in patients with primary nephrotic syndrome.Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1).Recipient rs1045642 Polymorphism Is Associated With Office Blood Pressure at 1-Year Post Kidney Transplantation: A Single Center Pharmacogenetic Cohort Pilot Study.
P2860
Q24186368-8872B50E-083C-43FD-9517-A09E6CCC58E5Q33421329-E9EF4891-EEA9-4FBC-AE06-715085FDF2A0Q34959857-1BB48583-6AB0-4504-9371-415B664D68BAQ36548717-72D85FBA-057B-4DAD-B385-1626D1C0564BQ36642796-EA1FAAEC-4E2A-423C-904F-7DC370BF8BEAQ37550548-60BAE8DE-FD1C-48A0-A88E-9A291618B837Q37554383-863CDBC1-3F02-4ABB-A035-7B705FAAA637Q38005228-C76FDE57-F0CF-41F9-8EDA-33D25809EDC9Q38025531-1F0CDCFB-6F41-428F-BF7F-9BD5FED66053Q38051705-030EFD6D-62BE-45F5-A7C7-EC7D8B6CF2D2Q38330651-28AC9D09-1C40-49F8-8594-87D515F253F7Q38501680-E753E97D-EC2D-4433-92FF-40591E82BDF8Q38668469-F826C897-9D6D-47D9-96E1-1C0BA7E60F0DQ38677027-551C49F0-AC32-49B2-84AA-2DBFD6C2FBD4Q38828972-8A6408BF-6709-4109-942A-2A4A77F6B3FAQ38903289-76EEAA62-161A-4011-9B06-2AE46641F12DQ38925600-930A6EDE-7A1B-4599-A45A-C66DB5EDDF27Q39140289-5AE116BB-8E20-45E4-91ED-498034E5C01CQ39636130-3F33AFA4-7B9F-46F3-A575-50863373F20DQ40192388-3B34C0F6-2FC6-401A-8E8C-BC7EE7767040Q42758588-DC693E33-18CF-4F6F-AC14-46462AE10ED6Q43893759-6109F8D7-1056-4414-80C4-7B14C0E8A914Q45046582-AEDE3887-7AA6-4A19-B5DC-4D761E529F14Q46225257-02F44091-E1C1-4767-A4E1-155167079582Q46654406-7E301996-EDF1-4A8B-BB59-9B7456A5D1B9Q46901195-8C1A3B17-07F5-4D8F-BD2A-3A068AC42052Q50062062-6DD6026B-3842-4A88-9D45-79E1A18F417AQ52576052-D874A060-B58F-44E9-BC33-44ED055C55F4Q54985931-020A667C-3571-4C50-9173-AFC60F89E96A
P2860
Identification of budesonide and prednisone as substrates of the intestinal drug efflux pump P-glycoprotein.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Identification of budesonide a ...... ug efflux pump P-glycoprotein.
@en
Identification of budesonide a ...... ug efflux pump P-glycoprotein.
@nl
type
label
Identification of budesonide a ...... ug efflux pump P-glycoprotein.
@en
Identification of budesonide a ...... ug efflux pump P-glycoprotein.
@nl
prefLabel
Identification of budesonide a ...... ug efflux pump P-glycoprotein.
@en
Identification of budesonide a ...... ug efflux pump P-glycoprotein.
@nl
P2093
P2860
P1476
Identification of budesonide a ...... ug efflux pump P-glycoprotein.
@en
P2093
Karin Dilger
Martin F Fromm
Matthias Schwab
P2860
P304
P356
10.1097/00054725-200409000-00012
P577
2004-09-01T00:00:00Z